FABP5 and hepatocellular carcinoma: Experimentally, GLA inhibited HCC cell proliferation and aggressiveness and promoted cell death-related pathways consistent with anti-tumor activity.<h4>Conclusion</h4>Our deep learning-guided workflow identified γ-linolenic acid as a natural FABP5 inhibitor and supports its potential as a lead compound for HCC therapy.